Skip to content

Insulin aspart

Fiasp, Novolog, NovoMix, NovoRapid (insulin aspart) is a protein pharmaceutical. Insulin aspart was first approved as Fiasp on 1999-09-07. It has been approved in Europe to treat diabetes mellitus.
Trade Name Fiasp, NovoMix, NovoRapid
Common Name Insulin aspart
Indication diabetes mellitus
Drug Class
Insulin aspart
Get full access now